Immunomedics Inc Watch

from 8-K 58 pages II Immunomedics, Inc. 14,736,860 Shares of Common Stock Underwriting Agreement

from 8-K 53 pages Immunomedics, Inc. 14,285,715 Shares of Common Stock Underwriting Agreement

from 8-K 37 pages Immunomedics, Inc. $150,000,000 Sales Agreement

from 8-K 55 pages Immunomedics, Inc. 11,500,000 Shares of Common Stock Underwriting Agreement

from 8-K 80 pages Immunomedics, Inc. 10,000,000 Shares of Common Stock and Warrants to Purchase 10,000,000 Shares of Common Stock Underwriting Agreement

from 8-K 55 pages Immunomedics, Inc. 9,000,000 Shares of Common Stock Underwriting Agreement

from 8-K 34 pages 6,086,956 Shares Immunomedics, Inc. Common Stock Underwriting Agreement

from 8-K ~10 pages Placement Agency Agreement

from S-3 27 pages Immunomedics, Inc. Form of Underwriting Agreement [Date]

from SC 13G/A 1 page Exhibit 1.1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on This Schedule 13g/A, Dated February 14, 2003, (The "Schedule 13g/A"), With Respect to the Common Stock, Par Value $0.01 Per Share, of Immunomedics, Inc. Is Filed on Behalf of Each of US Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities and Exchange Act of 1934, as Amended, and That This Agreement Shall Be Included as an Exhibit to This Schedule 13g/A. Each of the Undersigned Agrees to Be Responsible for the Timely Filing of the Schedule 13g/A, and for the Completeness and Accuracy of the Information Concerning Itself Contained Therein. This Agreement May Be Executed in Any Number of Counterparts, All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Have Executed This Agreement as of the 14th Day of February, 2003. Orbimed Advisors Inc. By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: President Orbimed Advisors LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: President of Managing Member, Orbimed Advisors Inc. By: /S/ Samuel D. Isaly Name: Samuel D. Isaly

from SC 13G 1 page Ex-1.1 Otherdoc 2 0002.txt Joint Filing Agreement Exhibit 1.1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on This Schedule 13g, Dated November 29, 2002, (The "Schedule 13g"), With Respect to the Common Stock, Par Value $0.01 Per Share, of Immunomedics Inc. Is Filed on Behalf of Each of US Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities and Exchange Act of 1934, as Amended, and That This Agreement Shall Be Included as an Exhibit to This Schedule 13g. Each of the Undersigned Agrees to Be Responsible for the Timely Filing of the Schedule 13g, and for the Completeness and Accuracy of the Information Concerning Itself Contained Therein. This Agreement May Be Executed in Any Number of Counterparts, All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Have Executed This Agreement as of the 29th Day of November, 2002. Orbimed Advisors Inc. By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: President Orbimed Advisors LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member

from SC 13G 1 page Ex-1.1 Otherdoc 2 0002.txt Joint Filing Agreement Exhibit 1.1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on This Schedule 13g, Dated November 29, 2002, (The "Schedule 13g"), With Respect to the Common Stock, Par Value $0.01 Per Share, of Immunomedics Inc. Is Filed on Behalf of Each of US Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities and Exchange Act of 1934, as Amended, and That This Agreement Shall Be Included as an Exhibit to This Schedule 13g. Each of the Undersigned Agrees to Be Responsible for the Timely Filing of the Schedule 13g, and for the Completeness and Accuracy of the Information Concerning Itself Contained Therein. This Agreement May Be Executed in Any Number of Counterparts, All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Have Executed This Agreement as of the 29th Day of November, 2002. Orbimed Advisors Inc. By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: President Orbimed Advisors LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member

from SC 13G 1 page Ex-1.1 Otherdoc 2 0002.txt Joint Filing Agreement Exhibit 1.1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on This Schedule 13g, Dated November 29, 2002, (The "Schedule 13g"), With Respect to the Common Stock, Par Value $0.01 Per Share, of Immunomedics Inc. Is Filed on Behalf of Each of US Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities and Exchange Act of 1934, as Amended, and That This Agreement Shall Be Included as an Exhibit to This Schedule 13g. Each of the Undersigned Agrees to Be Responsible for the Timely Filing of the Schedule 13g, and for the Completeness and Accuracy of the Information Concerning Itself Contained Therein. This Agreement May Be Executed in Any Number of Counterparts, All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Have Executed This Agreement as of the 29th Day of November, 2002. Orbimed Advisors Inc. By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: President Orbimed Advisors LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member

from SC 13D 1 page Exhibit 1 Agreement to File a Joint Statement by Their Signatures, the Undersigned Agree to File a Joint Schedule 13d and Understand That Such Statement Is Filed by or on Behalf of Each of Them. Dated: February 11, 1997 /S/ David M. Goldenberg David M. Goldenberg Dated: February 11, 1997 /S/ Deborah S. Orlove (Formerly Deborah S. Goldenberg) Deborah S. Orlove Dated: February 11, 1997 /S/ Eva J. Goldenberg Eva J. Goldenberg Dated: February 11, 1997 /S/ Neil A. Goldenberg Neil A. Goldenberg Dated: February 11, 1997 /S/ Lee R. Goldenberg Lee R. Goldenberg Escalon Corp. Dated: February 11, 1997 By: /S/ David M. Goldenberg David M. Goldenberg, President 15